Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Casanova · SciRah

Researcher profile · Semantic Scholar

M. Casanova

Share profile

M. Casanova — researcher profile on SciRah

h-index: 22
Works: 161
Citations: 3,163

Most-cited papers

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
J. Gisbert, María Chaparro, B. Verstockt, Peter Kienle +43 more
2026Journal of Crohn's & Colitis848 citations Open access
Semantic Scholar
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
H. Gordon, Silvia Minozzi, U. Kopylov, B. Verstockt +42 more
2024Journal of Crohn's & Colitis322 citations Open access
Semantic Scholar
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
M. Adamina, Silvia Minozzi, J. Warusavitarne, C. Buskens +42 more
2024Journal of Crohn's & Colitis134 citations Open access
Semantic Scholar
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
M. Chaparro, A. Garre, Andrea Núñez Ortiz, M. T. Diz-Lois Palomares +110 more
2021Journal of Clinical Medicine77 citations Open access
Semantic Scholar
Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry
M. Chaparro, A. Garre, M. Iborra, M. Sierra +74 more
2021Journal of Crohn's & Colitis69 citations Open access
Semantic Scholar
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease.
N. Noor, P. Sousa, D. Bettenworth, F. Gomollón +11 more
2023Journal of Crohn's & Colitis22 citations Open access
Semantic Scholar
Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
María José García, S. Riestra, A. Amiot, Mette Julsgaard +23 more
2024Alimentary Pharmacology and Therapeutics21 citations Open access
Semantic Scholar
Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
María José García, M. Rivero, A. Fernández-Clotet, R. de Francisco +46 more
2023Journal of Crohn's & Colitis21 citations
Semantic Scholar
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU
J. P. Gisbert, M. Donday, S. Riestra, A. Lucendo +54 more
2024Gut19 citations Open access
Semantic Scholar
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.
M. Casanova, B. Caballol, María José García, F. Mesonero +42 more
2024Digestive and Liver Disease18 citations
Semantic Scholar
Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA‐SWITCH study
M. Casanova, Ó. Nantes, P. Varela, M. Vela-González +38 more
2023Alimentary Pharmacology and Therapeutics15 citations
Semantic Scholar
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU
M. B. Acosta, A. Fernández-Clotet, F. Mesonero, F. García-Alonso +62 more
2022American Journal of Gastroenterology15 citations Open access
Semantic Scholar
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Cristina Rubín de Célix, J. Martín-de-Carpi, G. Pujol-Muncunill, L. Palomino +57 more
2023Journal of Clinical Medicine14 citations Open access
Semantic Scholar
Prophylactic versus endoscopy-driven treatment of Crohn's postoperative recurrence: A retrospective, multicentric European study (PORCSE study).
J. Geldof, M. Truyens, M. Hanssens, Emily Van Gucht +36 more
2024Journal of Crohn's & Colitis13 citations
Semantic Scholar
Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study
M. Casanova, M. Chaparro, Ó. Nantes, J. Benítez +21 more
2021Alimentary Pharmacology and Therapeutics12 citations
Semantic Scholar
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics
M. Orejudo, M. J. Gómez, S. Riestra, Montserrat Rivero +37 more
2025Frontiers in Cellular and Infection Microbiology10 citations Open access
Semantic Scholar
P744 Safety of live vaccines in children exposed to biological agents for inflammatory bowel disease (IBD) in utero or during breastfeeding
M. Chaparro, M. Donday, S. Rubio, C. Suárez +36 more
2023Journal of Crohn's & Colitis10 citations Open access
Semantic Scholar
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
R. Ferreiro-Iglesias, Sol Porto Silva, S. Marín, M. Casanova +70 more
2024Alimentary Pharmacology and Therapeutics8 citations
Semantic Scholar
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
H. Yanai, P. Ellul, B. Verstockt, T. Greuter +20 more
2026Journal of Crohn's & Colitis7 citations Open access
Semantic Scholar
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies
S. ten Bokkel Huinink, Doranne Thomassen, E. Steyerberg, R. Pauwels +16 more
2023Journal of Crohn's & Colitis7 citations Open access
Semantic Scholar
Headache in patients with inflammatory bowel disease: Migraine prevalence according to the Migraine Screening-Questionnaire (MS-Q) and headache characteristics.
A. González-Martínez, I. M. García, S. Quintas, M. Chaparro +6 more
2023Gastroenterology & hepatology7 citations
Semantic Scholar
Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW‐IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M. D. Martín-Arranz, R. de Francisco +72 more
2025Alimentary Pharmacology and Therapeutics6 citations
Semantic Scholar
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Celia Gómez-Labrador, Elena Ricart, M. Iborra, E. Iglesias +42 more
2024Pharmaceutics6 citations Open access
Semantic Scholar
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
M. Adamina, Peter Kienle, María Chaparro, B. Verstockt +43 more
2026Journal of Crohn's & Colitis5 citations Open access
Semantic Scholar
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation
M. Baldán-Martín, Cristina Rubín de Célix, Macarena Orejudo, L. Ortega-Moreno +15 more
2023International Journal of Molecular Sciences5 citations Open access
Semantic Scholar
OP04 Multi-Omics Biomarkers for Predicting Therapeutic Efficacy in Inflammatory Bowel Disease: Advancing Towards Tailored Treatments
M. Baldán-Martín, M. Azkargorta, A. Aransay, R. Gil-Redondo +32 more
2025Journal of Crohn's & Colitis4 citations
Semantic Scholar
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
I. Guerra, L. Bujanda, M. Mañosa, I. Pérez-Martínez +23 more
2023Cancers4 citations Open access
Semantic Scholar
Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease
I. Soleto, S. Fernández-Tomé, I. Mora-Gutiérrez, M. Baldán-Martín +10 more
2022Biomedicines4 citations Open access
Semantic Scholar
International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for Improvements
M. Casanova, J. P. Gisbert, A. Amiot, H. Gordon +27 more
2025United European Gastroenterology journal3 citations Open access
Semantic Scholar
Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU
M. Casanova, Cristina Rubín de Célix, S. Riestra, A. Lucendo +30 more
2025Alimentary Pharmacology and Therapeutics3 citations
Semantic Scholar
Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease.
A. Martín-Cardona, D. Horta, P. Flórez-Díez, M. Vela +23 more
2023Digestive and Liver Disease3 citations
Semantic Scholar
DOP52 Safety of Inflammatory Bowel Disease drugs during pregnancy and breastfeeding: Mothers and babies’ outcomes (DUMBO registry)
M. Chaparro, M. Donday, C. Suárez, S. Rubio +36 more
20213 citations
Semantic Scholar
P0692 Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU
M. Chaparro, S. Hermida, R. C. Camero, P. Abadía +36 more
2025Journal of Crohn's & Colitis2 citations
Semantic Scholar
P010 Faecal microbiota composition by shotgun metagenomic sequencing approach in a newly diagnosed cohort of inflammatory bowel disease patients: results from the IBDomics project
M. Orejudo, M. J. Gómez, R. de Francisco, M. Rivero +19 more
2024Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
M. Chaparro, A. Garre, Andrea Núñez Ortiz, M. T. Diz-Lois Palomares +109 more
2022Journal of Clinical Medicine2 citations Open access
Semantic Scholar
P545 Safety of ustekinumab in pregnant patients with inflammatory bowel disease and in their offspring: results from the DUMBO registry of GETECCU
M. Chaparro, A. Gutiérrez, C. Calvińo-Suárez, J. Huguet +36 more
2022Journal of Crohn's & Colitis2 citations
Semantic Scholar
P289 Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project
A. M. Cardona, D. Horta, P. Flórez-Díez, M. Vela +22 more
2022Journal of Crohn's & Colitis2 citations
Semantic Scholar
Editorial: Treatment Sequencing in Inflammatory Bowel Disease: Does the Line Matter More Than the Mechanism?
Susana Tomás, María Chaparro, M. Casanova
2026Alimentary Pharmacology and Therapeutics1 citations Open access
Semantic Scholar
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
T. Innocenti, J. Hanžel, M. Truyens, Milan Lukáš +43 more
2025Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
Psychomotor development in infants following maternal exposure to biologics: Results from the DUMBO registry.
L. Palomino, M. V. Rodríguez-Belvís, M. Casanova, E. Leo-Carnerero +53 more
2025Clinical Gastroenterology and Hepatology1 citations Open access
Semantic Scholar
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers.
M. Baldán-Martín, I. Iloro, M. Azkargorta, I. Soleto +37 more
2025Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
DOP22 Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine
M. Baldán-Martín, M. Azkargorta, A. Aransay, R. Gil-Redondo +31 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
I. Guerra, Francisco Barros, María Chaparro, J. Benítez +48 more
2024Digestive Diseases1 citations Open access
Semantic Scholar
P1141 Global perspectives on managing Inflammatory Bowel Disease (IBD) during pregnancy and lactation: current state and the necessity for enhancements
M. Casanova, J. Gisbert, A. Amiot, H. Gordon +27 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
P180 Novel biomarkers associated with inflammatory bowel disease
M. Baldán-Martín, I. Lloro, M. Azkargorta, M. Orejudo +24 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease
I. Soleto, M. Baldán, C. Ramírez, M. Orejudo +25 more
2023Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
OP27 Benefits of paediatric to adult transition program in Inflammatory Bowel Disease: The BUTTERFLY study of GETECCU
C. R. de Célix, J. M. de Carpi, G. Pujol, L. Palomino +36 more
2023Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
R. F. Iglesias, M. S. P. Porto Silva, S. Marín, M. Casanova +36 more
2022Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD)
M. García, M. Rivero, A. Fernández-Clotet, R. de Francisco +36 more
2022Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
P018 Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery
M. Baldán-Martín, M. Azkargorta, I. Iloro, L. O. Moreno +21 more
2022Journal of Crohn's & Colitis1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Rodríguez-Lago×20
Invite
I. Rodríguez-Lago — researcher profile on SciRah
R. de Francisco×17
Invite
R. de Francisco — researcher profile on SciRah
María Chaparro×16
Invite
María Chaparro — researcher profile on SciRah
S. Riestra×16
Invite
S. Riestra — researcher profile on SciRah

×16

Invite

M. Rivero — researcher profile on SciRah

F. Mesonero×16

Invite

F. Mesonero — researcher profile on SciRah

Invite

J. Gisbert — researcher profile on SciRah

Invite

Y. Ber — researcher profile on SciRah

M. Chaparro×14

Invite

M. Chaparro — researcher profile on SciRah

Manuel Barreiro-de Acosta×13

Invite

Manuel Barreiro-de Acosta — researcher profile on SciRah

Invite

J. Gisbert — researcher profile on SciRah

Invite

B. Sicilia — researcher profile on SciRah